COVID-19: Community Mitigation Strategies for Healthcare Providers

As the number of reported COVID-19 infections in the U.S. has increased significantly to 1701 cases as of this writing, the Centers for Disease Control and Prevention (CDC) has released important documentation on community-level mitigation strategies for COVID-19. This includes CDC’s latest guidance to healthcare providers and assisted and independent living facilities on methods to … Continue reading COVID-19: Community Mitigation Strategies for Healthcare Providers

CMS Announces Proposed Stark and Anti-Kickback Rule Revisions

On October 9, 2019, the Centers for Medicare & Medicaid Services announced two major proposed rule changes affecting both the Stark and Anti-Kickback Statutes. The first is “Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations” and the second, “Revisions To Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements.” … Continue reading CMS Announces Proposed Stark and Anti-Kickback Rule Revisions

A Compliance Program for Fraud, Waste, and Abuse in 7 Elements

If you own or run a clinical practice and bill Medicare or Medicaid, having a mature fraud, waste, and abuse compliance program is a critical part of business. In 2018, the U.S. Justice Department recovered $2.8 billion in civil cases involving fraud and false claims submitted to the Federal government. Of that figure, $2.5 billion … Continue reading A Compliance Program for Fraud, Waste, and Abuse in 7 Elements

FDA and DEA release first-ever joint warning to operators of websites marketing opioids online

In first-ever joint warnings, the FDA and DEA have sent letters to four online networks that operate 10 individual websites that market “unapproved and misbranded versions of opioid medicines, including tramadol, that are potentially dangerous. ” “Issuing these warning letters is not only an effort to deter the availability of dangerous illegal opioids, but it … Continue reading FDA and DEA release first-ever joint warning to operators of websites marketing opioids online